相关实验视频
Updated: May 30, 2025

07:29
Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
7.5K
布普伦诺芬:一个有新技巧的老狗
1Palliative care, Woodlands Hospice, Liverpool University Hospital Foundation Trust (LUHFT), Liverpool, UK.
Current opinion in supportive and palliative care
|January 31, 2025
概括
布普伦诺啡因在治疗癌症疼痛方面提供了独特的益处和有利的安全概况. 这次审查表明,它可能是癌症患者的有效一线阿片类药物治疗,改善疼痛管理结果.
科学领域:
- 在瘤学瘤学.
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症生存率有所改善,但疼痛仍然是许多需要阿片类药物治疗的患者面临的重大挑战.
- 目前的治疗通常涉及完全的片受体激动剂,布普伦诺芬通常被用作第二或第三线选择.
- 本次审查旨在重新评估布普伦诺芬在癌症疼痛管理中的作用.
研究的目的:
- 审查布普伦诺芬的药理学和临床效用.
- 激发关于布普伦诺芬在癌症疼痛中的潜在一线使用的讨论.
- 评估布普伦诺芬作为最初的阿片类药物选择在瘤学的适用性.
主要方法:
- 对布普伦诺芬的药理性质的文献综述.
- 对布普伦诺芬在癌症疼痛中的疗效和安全性的临床研究的分析.
- 综合证据支持或反驳一线使用.
主要成果:
- 与其他阿片类药物相比,布普伦诺芬具有独特的药理学特征.
- 它展示了许多短期和长期的优势,包括较低的不良影响风险.
- 这些特征使得布普伦诺芬成为癌症疼痛的潜在理想一线药物.
结论:
- 布普伦诺芬显示作为癌症患者的一线阿片类药物具有前途.
- 有证据表明,布普伦诺芬对广泛的患者是安全有效的.
- 它的形状支持考虑作为一种合适的初始治疗选择来管理与癌症相关的疼痛.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
211
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
211
Opioid Receptors: Overview
443
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
443
Analgesia and Pain Management
443
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
443
Opioid Analgesics: Morphine and Other Natural Cogeners
168
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
168
Drug Abuse and Addiction: Pharmacological Phenomena
432
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
432
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K

